Literature DB >> 29688994

Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models.

Séverine Ménoret1,2,3, Laure-Hélène Ouisse1,2,3, Laurent Tesson1,2,3, Frédéric Delbos1,2, Delphine Garnier1,2, Séverine Remy1,2,3, Claire Usal1,2,3, Jean-Paul Concordet4, Carine Giovannangeli4, Vanessa Chenouard1,2,3, Lucas Brusselle1,2,3, Emmanuel Merieau1,2, Véronique Nerrière-Daguin1,2, Franck Duteille5, Frédérique Bellier-Waast5, Alexandre Fraichard6, Tuan H Nguyen1,2, Ignacio Anegon1,2,3.   

Abstract

BACKGROUND: Immunodeficient mice are invaluable tools to analyze the long-term effects of potentially immunogenic molecules in the absence of adaptive immune responses. Nevertheless, there are models and experimental situations that would beneficiate of larger immunodeficient recipients. Rats are ideally suited to perform experiments in which larger size is needed and are still a small animal model suitable for rodent facilities. Additionally, rats reproduce certain human diseases better than mice, such as ankylosing spondylitis and Duchenne disease, and these disease models would greatly benefit from immunodeficient rats to test different immunogenic treatments.
METHODS: We describe the generation of Il2rg-deficient rats and their crossing with previously described Rag1-deficient rats to generate double-mutant RRG animals.
RESULTS: As compared with Rag1-deficient rats, Il2rg-deficient rats were more immunodeficient because they partially lacked not only T and B cells but also NK cells. RRG animals showed a more profound immunossuppressed phenotype because they displayed undetectable levels of T, B, and NK cells. Similarly, all immunoglobulin isotypes in sera were decreased in Rag1- or Il2rg-deficient rats and undetectable in Rats Rag1 and Il2rg (RRG) animals. Rag1- or Il2rg-deficient rats rejected allogeneic skin transplants and human tumors, whereas animals not only accepted allogeneic rat skin but also xenogeneic human tumors, skin, and hepatocytes. Immune humanization of RRG animals was unsuccessful.
CONCLUSIONS: Thus, immunodeficient RRG animals are useful recipients for long-term studies in which immune responses could be an obstacle, including tissue humanization of different tissues.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29688994     DOI: 10.1097/TP.0000000000002251

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.

Authors:  Séverine Bézie; Béatrice Charreau; Nadège Vimond; Juliette Lasselin; Nathalie Gérard; Véronique Nerrière-Daguin; Frédérique Bellier-Waast; Franck Duteille; Ignacio Anegon; Carole Guillonneau
Journal:  Blood Adv       Date:  2019-11-26

Review 2.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

3.  In Vivo Analysis of Human Immune Responses in Immunodeficient Rats.

Authors:  Séverine Ménoret; Laure-Hélène Ouisse; Laurent Tesson; Séverine Remy; Claire Usal; Aude Guiffes; Vanessa Chenouard; Pierre-Joseph Royer; Gwenaelle Evanno; Bernard Vanhove; Eliane Piaggio; Ignacio Anegon
Journal:  Transplantation       Date:  2020-04       Impact factor: 5.385

Review 4.  Stem Cell-Based Disease Models for Inborn Errors of Immunity.

Authors:  Aline Zbinden; Kirsten Canté-Barrett; Karin Pike-Overzet; Frank J T Staal
Journal:  Cells       Date:  2021-12-30       Impact factor: 6.600

Review 5.  Recent Advances in the Production of Genome-Edited Rats.

Authors:  Masahiro Sato; Shingo Nakamura; Emi Inada; Shuji Takabayashi
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

6.  A high-quality severe combined immunodeficiency (SCID) rat bioresource.

Authors:  Yoshiki Miyasaka; Jinxi Wang; Kosuke Hattori; Yuko Yamauchi; Miho Hoshi; Kazuto Yoshimi; Saeko Ishida; Tomoji Mashimo
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

7.  Generation and characterization of an I l2rg knockout Syrian hamster model for XSCID and HAdV-C6 infection in immunocompromised patients.

Authors:  Rong Li; Baoling Ying; Yanan Liu; Jacqueline F Spencer; Jinxin Miao; Ann E Tollefson; James D Brien; Yaohe Wang; William S M Wold; Zhongde Wang; Karoly Toth
Journal:  Dis Model Mech       Date:  2020-08-27       Impact factor: 5.758

8.  The SRG rat, a Sprague-Dawley Rag2/Il2rg double-knockout validated for human tumor oncology studies.

Authors:  Fallon K Noto; Jaya Sangodkar; Bisoye Towobola Adedeji; Sam Moody; Christopher B McClain; Ming Tong; Eric Ostertag; Jack Crawford; Xiaohua Gao; Lauren Hurst; Caitlin M O'Connor; Erika N Hanson; Sudeh Izadmehr; Rita Tohmé; Jyothsna Narla; Kristin LeSueur; Kajari Bhattacharya; Amit Rupani; Marwan K Tayeh; Jeffrey W Innis; Matthew D Galsky; B Mark Evers; Analisa DiFeo; Goutham Narla; Tseten Y Jamling
Journal:  PLoS One       Date:  2020-10-07       Impact factor: 3.240

9.  Survival-Assured Liver Injury Preconditioning (SALIC) Enables Robust Expansion of Human Hepatocytes in Fah-/- Rag2-/- IL2rg-/- Rats.

Authors:  Ludi Zhang; Jian-Yun Ge; Yun-Wen Zheng; Zhen Sun; Chenhua Wang; Zhaoliang Peng; Baihua Wu; Mei Fang; Kinji Furuya; Xiaolong Ma; Yanjiao Shao; Nobuhiro Ohkohchi; Tatsuya Oda; Jianglin Fan; Guoyu Pan; Dali Li; Lijian Hui
Journal:  Adv Sci (Weinh)       Date:  2021-08-11       Impact factor: 16.806

10.  Cutaneous and Pulmonary Mucormycosis in Rag1- and Il2rg-deficient Rats.

Authors:  Anna E Sarfaty; Susan R Compton; Peter C Smith; Caroline J Zeiss
Journal:  Comp Med       Date:  2020-07-31       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.